[FAIT (FU arterial infusion and interferon therapy) for hepatocellular carcinoma].

@article{Nagano2006FAITA,
  title={[FAIT (FU arterial infusion and interferon therapy) for hepatocellular carcinoma].},
  author={Hiroaki Nagano and Morito Monden},
  journal={Nihon rinsho. Japanese journal of clinical medicine},
  year={2006},
  volume={64 7},
  pages={1314-8}
}
We summarised the beneficial effects of FAIT (FU Arterial Infusion and Interferon Therapy) for advanced hepatocellular carcinoma (HCC). In the 55 patients of HCC with portal venous tumour thrombi (PVTT) treated with FAIT alone, 24 (43.6%) showed objective response, 4 (7.3%) showed no response, and 27 (49.1%) showed progressive disease. In the 15 patients of HCC with PVTT treated with FAIT and surgery, all of the cases (100%) survived over 1 year; without FAIT and surgery, 10 patients (67%) were… CONTINUE READING

From This Paper

Topics from this paper.

Similar Papers

Loading similar papers…